A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2004
10/26/2004	CA2335713C Oral dosage form
10/26/2004	CA2266759C 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
10/26/2004	CA2080462C Therapeutic uses of actin-binding compounds
10/21/2004	WO2004089992A1 Modified acacia and use thereof
10/21/2004	WO2004089976A1 Method of treatment
10/21/2004	WO2004089964A1 Lipid-regulating agent and use thereof
10/21/2004	WO2004089936A1 Heteroarylsulfonanilide derivative and medicinal composition containing the same
10/21/2004	WO2004089913A1 Aminopyrimidine derivatives and their medical use
10/21/2004	WO2004089900A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004	WO2004089899A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
10/21/2004	WO2004089414A2 Combinations of proton pump inhibitors or blockers with prokinetic agents
10/21/2004	WO2004089378A1 Medicinal composition containing pyrrolopyridazine derivative
10/21/2004	WO2004089364A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004	WO2004089363A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
10/21/2004	WO2004089350A1 Use of an ibat inhibitor for the treatment of prophylaxis of constipation
10/21/2004	WO2004089333A2 A stable benzimidazole formulation
10/21/2004	WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
10/21/2004	WO2003045228A3 Methods for treating autoimmune disorders, and reagents related thereto
10/21/2004	US20040210080 3-(oxo, oxime, hydrazone, or alkylidene)-fluorene derivatives; can be synergistically combined with other anticarcinogenic, anticholesterol, anxiolytic agents, antidepressants or enzyme inhibitors; bone disorders
10/21/2004	US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles
10/21/2004	US20040210042 Polypeptides relating to signal transfer of advanced glycation end product receptor
10/21/2004	US20040209961 Treatment of intestinal conditions with N-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine
10/21/2004	US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/21/2004	US20040209935 Pyrazole-derived kinase inhibitors and uses thereof
10/21/2004	US20040209934 Protein phosphate inhibitors
10/21/2004	US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
10/21/2004	US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
10/21/2004	US20040209901 substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors.
10/21/2004	US20040209899 A2B adenosine receptor antagonists
10/21/2004	US20040209893 treatment of a condition mediated by a tachykinin including substance P and other neurokinins by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic Acid (3,5-bistrifuoromethyl-benzyl)-methyl-amide Hydrochloride .
10/21/2004	US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
10/21/2004	US20040209870 contain 5-HT ligands used to treat central nervous system disorders
10/21/2004	US20040209868 Substituted indoles
10/21/2004	US20040209843 addtion of a cyclodextrin compound increases the water solubility; storage stable solution; immediately treating symptoms of acute phases of myocardial or a cerebral infarction
10/21/2004	US20040209826 Diphosphate salt of a "4" - substituted-9-deoxo-9 A - AZA - homoerythromycin derivatives and its pharmaceutical composition
10/21/2004	US20040209805 such as fibrosis via activin antagonist (fullistatin); kits; gene therapy; treating inflammatory bowel disease and crohn's disease
10/21/2004	US20040209798 biodrugs for treatment of lung cancer, glioma, anorexia, hypothyroidism, hyperaldosteronism, H. pylori proliferation, acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites
10/21/2004	US20040209306 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
10/21/2004	US20040208941 Compositions for removal of toxins
10/21/2004	US20040208924 active pharmaceutical ingredient is for example [(2S)-Sulfanyl-5-[(N,N-dimethylamino)acetyl]aminopentanoyl-L-leucyl-L-tert-leucine N-methylamide; bonding strength, stability
10/21/2004	US20040208857 Producing a donor-specific immunotolerance against transplanted tissue by administering embryonic stem cell-like cell lines (ECL) obtained from blastocysts and are transfected with genetic material of the donor, which codes for the major histocompatibility complex (MHC) haplotypes
10/21/2004	US20040208834 Oral-use polymer and oral-use composition
10/21/2004	CA2522071A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004	CA2521989A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004	CA2521788A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
10/21/2004	CA2521692A1 Modified acacia and use thereof
10/21/2004	CA2521340A1 Aminopyrimidine derivatives and their medical use
10/20/2004	EP1469077A1 Cell-specific expression/replication vector
10/20/2004	EP1469009A2 Compositions and methods for non-parenteral delivery of oligonucleotides
10/20/2004	EP1469008A1 Method of preparing a non-pharmaceutical grade clarithromycin
10/20/2004	EP1468991A1 Imides as PDE III, PDE IV and TNF inhibitors
10/20/2004	EP1468075A1 Novel lactobacillus sp. strain and use thereof
10/20/2004	EP1468019A2 Secreted protein
10/20/2004	EP1468018A2 Leptin proteins
10/20/2004	EP1468017A1 A complex of a human foxc2 protein and a foxc2-interacting protein
10/20/2004	EP1467997A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
10/20/2004	EP1467995A2 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
10/20/2004	EP1467991A1 Prucalopride-n-oxide
10/20/2004	EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/20/2004	EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
10/20/2004	EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
10/20/2004	EP1467972A1 Indazole compounds useful as protein kinase inhibitors
10/20/2004	EP1467770A1 Pantoprazole cyclodextrin inclusion complexes
10/20/2004	EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS
10/20/2004	EP1467745A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders
10/20/2004	EP1467742A1 Use of alkylphosphocholines for the preventative treatment of protozoan diseases
10/20/2004	EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
10/20/2004	EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
10/20/2004	EP1467739A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
10/20/2004	EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
10/20/2004	EP1467726A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
10/20/2004	EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis
10/20/2004	EP1467714A1 Drug mixture with enhanced dissolution rate
10/20/2004	EP1368327B1 Benzo thiadiazine matrix metalloproteinase inhibitors
10/20/2004	EP1307264B1 New pharmaceutical composition
10/20/2004	EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/20/2004	EP1263725B1 Novel compounds
10/20/2004	EP1230236B1 Compound with growth hormone releasing properties
10/20/2004	EP1217902B1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
10/20/2004	EP1181381B1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
10/20/2004	EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/20/2004	EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors
10/20/2004	EP1112253B1 Branched alkyl pyrrolidine-3-carboxylic acids
10/20/2004	EP1105156B1 Non-virulent porphyromonas gingivalis mutant
10/20/2004	EP0830136B1 New cryptophycins from synthesis
10/20/2004	CN1539019A Process for producing 1,4-dihydroxy-2-naphthoic acid
10/20/2004	CN1539010A Fermentation product of cryptoporus volvatus and its preparation method and application
10/20/2004	CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease
10/20/2004	CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins
10/20/2004	CN1538959A Fused-polycyclic compounds
10/20/2004	CN1538956A Spiro compounds
10/20/2004	CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells
10/20/2004	CN1538848A Novel Benzo-fused heterocycles
10/20/2004	CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
10/20/2004	CN1538836A Substituted amine derivatives and method of use
10/20/2004	CN1537864A Fern effective part and compound fern glycoside and its separaton and purification method
10/20/2004	CN1537849A Hydroxy stilbene kind compound and its preparation method and application
10/20/2004	CN1537652A Health-care stomach pocket with gold and Chinese medicine and its manufacturing method
10/20/2004	CN1537628A Purpleblow maple lozenge for health-care,and its prepn. method
10/20/2004	CN1537627A Capsule for treating hepatopathy

1 ... 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 ... 1258